FDA Approves New H1N1 Vaccine

The Federal Food and Drug Administration has approved a supplemental biologics license application for a new H1N1 vaccine made by GlaxoSmithKline.

The approval allows the company to manufacture flu vaccines for adults which target this year's H1N1 strain. The Department of Health and Human Services has already placed an order with the drugmaker for 7.6 million doses.

GlaxoSmithKline expects to begin shipping the vaccine in December.

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus

275 E. Arlington Blvd. Greenville, NC 27858 252-439-7777
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 69739987 - witn.com/a?a=69739987
Gray Television, Inc.